Zusammenfassung
Klinisches/methodisches Problem
Das kolorektale Karzinom ist eines der häufigsten malignen Tumoren. Die präoperative Bildgebung ist beim Rektumkarzinom entscheidend, da die Patienten nur bei akkuratem Staging einem optimalen Behandlungskonzept zugeführt werden können. Das N‑Staging gestaltet sich oft schwierig und muss als Staging-Parameter infrage gestellt werden.
Radiologische Standardverfahren
Für das lokale Staging eignen sich der endorektale Ultraschall (EUS) und die Magnetresonanztomographie (MRT). Die multiparametrische MRT samt Diffusionsbildgebung ist bei der Tumornachsorge unverzichtbar.
Methodische Innovationen
Mittels hochauflösender MRT gelingt die Beurteilung der Infiltration der mesorektalen Faszie am besten. Als weiterer wichtiger prognostischer Faktor hat sich zudem die extramurale Gefäßinfiltration (EMVI) etabliert. Nach neoadjuvanter Therapie und Restaging des lokal fortgeschrittenen Rektumkarzinoms steht die Identifizierung und Validierung prognostisch relevanter Bildparameter im Vordergrund. Die multiparametrische MRT des Rektums inklusive Diffusionsbildgebung sowie die Anwendung radiologisch-pathologischer Scores (MR-TRG) spielen hier eine bedeutende Rolle.
Bewertung
Für den Radiologen ist es wichtig, sich mit Indikatoren der Resektabilität des Rektumkarzinoms vertraut zu machen und prognostisch relevante Bildparameter in der Tumornachsorge sicher lesen zu können.
Empfehlung für die Praxis
Für die praktische Anwendung ist die Etablierung eines festen MRT-Protokolls unerlässlich. Neben der leitliniengerechten TNM-Klassifizierung muss der Radiologe dem Kliniker auch Informationen über die Infiltration der mesorektalen Faszie und der extramurale Gefäßinfiltration vermitteln. In der Tumornachsorge gewinnen radiologisch-pathologischen Scores (MR-TRG) zunehmend an Bedeutung.
Abstract
Clinical/methodical issue
Colorectal cancer is one of the most common malignant tumors. Preoperative imaging is crucial in rectal cancer as patients can only receive optimal treatment when accurate staging is performed. The N‑staging is often difficult with the available options and must be called into question as a staging parameter.
Standard radiological methods
Endoscopic ultrasound (EUS) and magnetic resonance imaging (MRI) are particularly suitable for local staging. Multiparametric MRI with diffusion imaging is indispensable for tumor follow-up.
Methodical innovations
The assessment of infiltration of the mesorectal fascia is best accomplished using high-resolution MRI. In addition, extramural vascular infiltration (EMVI) has become established as another important prognostic factor. After neoadjuvant therapy and restaging of locally advanced rectal cancer, the identification and validation of prognostically relevant image parameters are prioritized. Multiparametric MRI of the rectum including diffusion imaging as well as the application of radiological and pathological scores (MR-TRG) are becoming increasingly more important in this context.
Assessment
For the radiologist it is important to become familiar with indicators of the resectability of rectal cancer and to be able to reliably read prognostically relevant imaging parameters in the tumor follow-up.
Practical recommendations
For the practical application, the establishment of a fixed MRI protocol is essential. In addition to a guideline-compliant TNM classification, the radiologist must provide the clinician with information on infiltration of the mesorectal fascia and extramural vascular infiltration. The MR-TRGs are becoming increasingly more important in tumor follow-up.
Literatur
Bertz J, Hentschel S, Hundsdörfer G et al (2004) Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland, S 28–31
Puli SR, Bechtold ML, Reddy JB et al (2009) How good is endoscopic ultrasound in differentiating various T stages of rectal cancer? Meta-analysis and systematic review. Ann Surg Oncol 16(2):254–265. https://doi.org/10.1245/s10434-008-0231-5
Lindmark GE, Kraaz WG, Elvin PA et al (1997) Rectal cancer: evaluation of staging with endosonography. Radiology 204:533–538
Marusch F, Koch A, Schmidt U et al (2002) Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study. Endoscopy 34:385–390
Harewood GC (2005) Assessment of publication bias in the reporting of EUS performance in staging rectal cancer. Am J Gastroenterol 100:808–816
Juchems MS, Ernst AS, Kornmann M et al (2009) Value of MDCT in preoperative local staging of rectal cancer for predicting the necessity for neoadjuvant radiochemotherapy. Rofo 181:1168–1174
Kim NK, Kim MJ, Yun SH et al (1999) Comparative study of transrectal ultrasonography, pelvic computerized tomography, and magnetic resonance imaging in preoperative staging of rectal cancer. Dis Colon Rectum 42:770–775
Ward J, Robinson PJ, Guthrie JA et al (2005) Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 237:170–180
Selzner M, Hany TF, Wildbrett P et al (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027–1034 (discussion 1035–1026)
Kim CK, Kim SH, Choi D et al (2007) Comparison between 3‑T magnetic resonance imaging and multi-detector row computed tomography for the preoperative evaluation of rectal cancer. J Comput Assist Tomogr 31:853–859
Beets-Tan RG, Beets GL, Vliegen RF et al (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357:497–504
Poon FW, Mcdonald A, Anderson JH et al (2005) Accuracy of thin section magnetic resonance using phased-array pelvic coil in predicting the T‑staging of rectal cancer. Eur J Radiol 53:256–262
Glynne-Jones R, Tan D, Goh V (2014) Pelvic MRI for guiding treatment decisions in rectal cancer. Oncology (Williston Park, NY) 28:667–677
Will O, Purkayastha S, Chan C et al (2006) Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 7:52–60
Heijnen LA, Lambregts DM, Mondal D et al (2013) Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur Radiol 23:3354–3360
Zhang H, Zhang C, Zheng Z et al (2017) Chemical shift effect predicting lymph node status in rectal cancer using high-resolution MR imaging with node-for-node matched histopathological validation. Eur Radiol 27:3845–3855
Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg 253:711–719
Taylor FG, Quirke P, Heald RJ et al (2014) Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5‑year follow-up results of the MERCURY study. J Clin Oncol 32:34–43
Siddiqui MRS, Simillis C, Hunter C et al (2017) A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. Br J Cancer 116:1513–1519
Sohn B, Lim JS, Kim H et al (2015) MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol 25:1347–1355
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, Awmf) (2019) S3-Leitlinie Kolorektales Karzinom, Kurzversion 2.1. http://www.leitlinienprogramm-onkologie.de/Leitlinien/Kolorektales-Karzinom/ (Awmf Registrierungsnummer: 021/007ol)
Glynne-Jones R, Wyrwicz L, Tiret E et al (2017) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv22–iv40
Körner H, Söreide K, Stokkeland PJ et al (2005) Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 9:320–328
Wichmann MW, Müller C, Hornung HM et al (2002) Results of long-term follow-up after curative resection of Dukes A colorectal cancer. World J Surg 26:732–736
Merkel S, Meyer T, Göhl J et al (2002) Late locoregional recurrence in rectal carcinoma. Eur J Surg Oncol 28:716–722
Bülow S, Christensen IJ, Harling H et al (2003) Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg 90:974–980
Berman JM, Cheung RJ, Weinberg DS (2000) Surveillance after colorectal cancer resection. Lancet 355:395–399
Mäkelä JT, Laitinen SO, Kairaluoma MI (1995) Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 130:1062–1067
Hünerbein M, Totkas S, Moesta KT et al (2001) The role of transrectal ultrasound-guided biopsy in the postoperative follow-up of patients with rectal cancer. Surgery 129:164–169
Mitry E, Guiu B, Cosconea S et al (2010) Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut 59:1383–1388
Schoemaker D, Black R, Giles L et al (1998) Yearly colonoscopy, liver CT, and chest radiography do not influence 5‑year survival of colorectal cancer patients. Baillieres Clin Gastroenterol 114:7–14
Pietra N, Sarli L, Costi R et al (1998) Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 41:1127–1133
Jeffery GM, Hickey BE, Hider P (2002) Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 1:CD2200
Winawer S, Fletcher R, Rex D et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Baillieres Clin Gastroenterol 124:544–560
Sobhani I, Tiret E, Lebtahi R et al (2008) Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer 98:875–880
Selvaggi F, Cuocolo A, Sciaudone G et al (2003) FGD-PET in the follow-up of recurrent colorectal cancer. Colorectal Dis 5:496–500
Maas M, Beets-Tan RG et al (2011) Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633–4640
Pucciarelli S, De Paoli A et al (2013) Local excision after preoperative Chemoradiotherapy for rectal cancer: results of a Multicenter phase II clinical trial. Dis Colon Rectum 56:1349–1356
Wietek BM (2012) KraTT t: Aktuelle MRT-Diagnostik des Rektumkarzinoms. Rofo 184(11):992–1001
Kochhar R, Renehan AG, Mullan D, Chakrabarty B, Saunders MP, Carrington BM (2017) The assessment of local response using magnetic resonance imaging at 3‑ and 6‑month post chemoradiotherapy in patients with anal cancer. Eur Radiol 27(2):607–617
Shihab OC, Taylor F, Salerno G, Heald RJ, Quirke P, Moran BJ et al (2011) MRI predictive factors for long-term outcomes of low rectal tumours. Ann Surg Oncol 18:3278–3284
Bhoday J, Smith F, Siddiqui MR, Balyasnikova S, Swift RI, Perez R, Habr-Gama A, Brown G (2016) Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy. Dis Colon Rectum 59:925–933
Birlik B, Obuz F, Elibol FD, Celik AO, Sokmen S, Terzi C et al (2015) Diffusion-weighted MRI and MR—volumetry—in the evaluation of tumor response after preoperative Chemoradiotherapy in patients with locally advanced rectal cancer. Magn Reson Imaging 33(2):201–212
Lambregts DM, Maas M, Riedl RG, Bakers FC, Verwoerd JL, Kessels AG et al (2011) Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer—a per lesion validation study. Eur Radiol 21(2):265–273
Gollub MJ, Blazic I, Felder S, Knezevic A, Gonen M, Garcia-Aguilar J, Paty PP, Smith JJ (2019) Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer. Eur Radiol 29(3):1104–1113
De Cecco CN, Ganeshan B, Ciolina M, Rengo M, Meinel FG, Musio D et al (2015) Texture analysis as imaging biomarker of tumoral response to Neoadjuvant Chemoradiotherapy in rectal cancer patients studied with 3‑T magnetic resonance. Invest Radiol 50(4):239–245
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M.S. Juchems und J. Wessling geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Rights and permissions
About this article
Cite this article
Juchems, M.S., Wessling, J. Rationales Staging und Follow-up beim kolorektalen Karzinom. Radiologe 59, 820–827 (2019). https://doi.org/10.1007/s00117-019-0578-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-019-0578-6